Mumbai, India

Rosalind Adaikalasamy Marita

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Rosalind Adaikalasamy Marita

Introduction

Rosalind Adaikalasamy Marita is a notable inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic disorders. With a total of three patents to her name, her work focuses on developing novel compounds that address critical health issues.

Latest Patents

One of her latest patents involves pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia. This invention provides novel compounds represented by a specific general formula, including their stereoisomers, pharmaceutically acceptable salts, and solvates. These compounds are designed to be effective in treating metabolic disorders associated with insulin resistance or hyperglycemia. Additionally, she has developed 3-amino-pyridine derivatives for similar therapeutic purposes. This patent also outlines a process for manufacturing these compounds and pharmaceutical compositions containing them.

Career Highlights

Throughout her career, Rosalind has worked with prominent companies such as Piramal Healthcare Limited and Piramal Life Sciences Limited. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Some of her notable coworkers include Nabajyoti Deka and Sivaramakrishnan Hariharan. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Rosalind Adaikalasamy Marita's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…